Products and Services

Aptar Pharma has transferred manufacturing equipment for its Child-Resistant and Senior-Friendly Classic Nasal Pump from a plant in Germany to its facility in Congers, NY, the company said. According to Aptar, its child-resistant pump is… Read more . . .

Device company Nemera has announced a partnership with the Research Center for Respiratory Diseases (CEPR) at the University of Tours for investigation of a novel intranasal drug delivery method. Nemera, which was formerly known as… Read more . . .

Generic device company Merxin has announced the launch of its MRX003 dry powder inhaler, an off-the-shelf capsule based DPI intended for generic tiotropium 505j submissions. According to an announcement by Merxin’s sister company Aedestra, the… Read more . . .

Lactose manufacturer Meggle has announced the launch of InhaLac 500 micronized lactose for dry powder inhalation formulations, saying “Combined with high quality and safety, this material meets the most demanding individual dry powder inhalation formulation… Read more . . .

Dalton Pharma Services will take responsibility for GMP preparation and filling into glass vials of Arch Biopartners’ AB569 bactericidal inhalation solution for an upcoming Phase 1 trial, the companies have announced. Dalton will provide a… Read more . . .

H&T Presspart has announced its acquisition of global rights to a capsule-based dry powder inhaler developed by Hovione. H&T Presspart will manufacture and commercialize the DPI, which will be marketed as PowdAir Plus. According to… Read more . . .

Capsugel has added a new Harro Hӧfliger Modu-C MS encapsulation unit with a capacity of over 72,000 capsules per hour for late-stage clinical trial and commercial production of dry powder inhaler formulations, the company said.… Read more . . .

Connected health company Cohero Health has added $1.5 million from new investors Samsung NEXT and Omron Healthcare to its Series A round, the company said. In November 2016, Cohero announced closure of the $9 million… Read more . . .

US-based MedInvent has obtained CE Marking and ISO 13485 and CMDCAS certification for its NasoNeb II nasal nebulizer, the company said. The company has also signed a distribution contract with Vedise Hospital in Rome, Italy,… Read more . . .